-+ 0.00%
-+ 0.00%
-+ 0.00%

Pacific Biosciences Sees FY2026 Sales $165.000M-$175.000M vs $173.371M Est

Benzinga·05/07/2026 20:14:11
Listen to the news
Pacific Biosciences (NASDAQ:PACB) sees FY2026 sales of $165.000 million-$175.000 million vs $173.371 million analyst estimate.